To find out if a defective expression of inhibitory receptors could be associated with the B-cell hyperactivity observed in SSc patients, the surface expression of CD22, Siglec 10, CD35, and FcγRIIB was examined on B cells from SSc patients and healthy subjects. The gene discussed is FCGR2B; the disease is systemic sclerosis.